Trial NCT02780830

View at ClinicalTrials.gov 
Org. Study IDs: D2276C00001
Secondary IDs: LYM 103

Last trial update was posted on 2016-09-15

MeSH Interventions

Ibrutinib

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma Module 1: Non-GCB Diffuse Large B-Cell Lymphoma

Stopping Reasons

Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an alternate design.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID